Zevalin is composed of the murine monoclonal antibody ibritumomab that is linked to the chelator tiuxetan, which binds the 90Y radioisotope.
Zevalin se compose de l’anticorps monoclonal murin ibritumomab combiné au chélateur tiuxétan, qui lie le radio-isotope 90Y.